About Kymanox
Kymanox is a company based in King Of Prussia (United States) founded in 2017 by Satoshi Matsushita was acquired by Kymanox in August 2021. It operates as a Professional Services. Kymanox offers products and services including Device Design & Development, Container Design & Development, Electrical & Software Design, and Sterilization Engineering.
- Headquarter King Of Prussia, United States
- Founders Satoshi Matsushita
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kymanox Corporation
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kymanox
Kymanox offers a comprehensive portfolio of products and services, including Device Design & Development, Container Design & Development, Electrical & Software Design, and Sterilization Engineering.
User-centric devices are crafted for functionality and experience.
Packaging solutions are designed for quality and sustainability.
Custom electronics and software are developed for devices.
Robust sterilization processes are developed for product quality.
Funding Insights of Kymanox
Detailed funding history for Kymanox
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Kymanox
Kymanox has secured backing from 1 investor. Prominent investors backing the company include Kymanox.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Commercialization, validation, and consulting services for vital medicines are provided.
|
Locked | Locked | Locked |
Investor details for Kymanox
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kymanox
Investment portfolio details for Kymanox
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kymanox
Detailed financials for Kymanox
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kymanox Comparisons
Peer comparison for Kymanox
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kymanox
Detailed competitors of Kymanox
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kymanox
Complete news archive for Kymanox
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kymanox
Kymanox was founded in 2017.
Kymanox is headquartered in King Of Prussia, United States. It is registered at King Of Prussia, Pennsylvania, United States.
Kymanox is involved in providing design and innovation services for medical devices, combination products, and pharmaceuticals. The company operates in sectors such as biotechnology and diagnostics, offering solutions in product development, human factors engineering, and sterilization processes. Services include mechanical and electrical design, container development, and regulatory compliance support. Projects are progressed through various design phases using principles like Design for Manufacturing and Assembly to ensure successful market entry.
Kymanox offers Device Design & Development, Container Design & Development, Electrical & Software Design, and Sterilization Engineering.
Kymanox has 1 investor. Key investors include Kymanox.